Experimental Lymphedema: Can Cellular Therapies Augment the Therapeutic Potential for Lymphangiogenesis?

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2012 Nov 7

PMID 23130177

Citations 2

Authors

Stanley G Rockson

Affiliations

Soon will be listed here.

Citing Articles

Direct three-dimensional printed egg white hydrogel wound dressing promotes wound healing with hitching adipose stem cells.

Wang X, Ma Y, Niu X, Su T, Huang X, Lu F Front Bioeng Biotechnol. 2022; 10:930551.

PMID: 36072289 PMC: 9441893. DOI: 10.3389/fbioe.2022.930551.

Influence of Adipose Tissue-Derived Stem Cells on the Burn Wound Healing Process.

Franck C, Senegaglia A, Boldrini Leite L, Moura S, Francisco N, Ribas Filho J Stem Cells Int. 2019; 2019:2340725.

PMID: 30886634 PMC: 6388323. DOI: 10.1155/2019/2340725.

References

Goldman J, Conley K, Raehl A, Bondy D, Pytowski B, Swartz M . Regulation of lymphatic capillary regeneration by interstitial flow in skin. Am J Physiol Heart Circ Physiol. 2006; 292(5):H2176-83. DOI: 10.1152/ajpheart.01011.2006. View

Szuba A, Skobe M, Karkkainen M, Shin W, Beynet D, Rockson N . Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 2002; 16(14):1985-7. DOI: 10.1096/fj.02-0401fje. View

Shimizu Y, Shibata R, Shintani S, Ishii M, Murohara T . Therapeutic lymphangiogenesis with implantation of adipose-derived regenerative cells. J Am Heart Assoc. 2012; 1(4):e000877. PMC: 3487362. DOI: 10.1161/JAHA.112.000877. View

Zampell J, Avraham T, Yoder N, Fort N, Yan A, Weitman E . Lymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines. Am J Physiol Cell Physiol. 2011; 302(2):C392-404. PMC: 3328842. DOI: 10.1152/ajpcell.00306.2011. View

Hodge L, Downey H . Lymphatic pump treatment enhances the lymphatic and immune systems. Exp Biol Med (Maywood). 2011; 236(10):1109-15. DOI: 10.1258/ebm.2011.011057. View

Yan A, Avraham T, Zampell J, Haviv Y, Weitman E, Mehrara B . Adipose-derived stem cells promote lymphangiogenesis in response to VEGF-C stimulation or TGF-β1 inhibition. Future Oncol. 2011; 7(12):1457-73. PMC: 3263831. DOI: 10.2217/fon.11.121. View

Choi I, Lee S, Hong Y . The new era of the lymphatic system: no longer secondary to the blood vascular system. Cold Spring Harb Perspect Med. 2012; 2(4):a006445. PMC: 3312397. DOI: 10.1101/cshperspect.a006445. View

Rutkowski J, Moya M, Johannes J, Goldman J, Swartz M . Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res. 2006; 72(3):161-71. PMC: 2676671. DOI: 10.1016/j.mvr.2006.05.009. View

Ridner S . The psycho-social impact of lymphedema. Lymphat Res Biol. 2009; 7(2):109-12. PMC: 2904185. DOI: 10.1089/lrb.2009.0004. View

10.

Jin D, An A, Liu J, Nakamura K, Rockson S . Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization. Lymphat Res Biol. 2009; 7(1):47-57. DOI: 10.1089/lrb.2009.0002. View

11.

Szuba A, Shin W, Strauss H, Rockson S . The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003; 44(1):43-57. View

12.

Shin W, Rockson S . Animal models for the molecular and mechanistic study of lymphatic biology and disease. Ann N Y Acad Sci. 2008; 1131:50-74. DOI: 10.1196/annals.1413.005. View

13.

Velanovich V, Szymanski W . Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999; 177(3):184-7; discussion 188. DOI: 10.1016/s0002-9610(99)00008-2. View

14.

Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H . Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation. 2006; 114(11):1177-84. DOI: 10.1161/CIRCULATIONAHA.105.602953. View

15.

Nakamura K, Rockson S . Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease. Lymphat Res Biol. 2008; 6(3-4):181-9. DOI: 10.1089/lrb.2008.63404. View

16.

Oliver G . Lymphatic vasculature development. Nat Rev Immunol. 2004; 4(1):35-45. DOI: 10.1038/nri1258. View

17.

Norrmen C, Tammela T, Petrova T, Alitalo K . Biological basis of therapeutic lymphangiogenesis. Circulation. 2011; 123(12):1335-51. DOI: 10.1161/CIRCULATIONAHA.107.704098. View

18.

Yoon Y, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C . VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest. 2003; 111(5):717-25. PMC: 151891. DOI: 10.1172/JCI15830. View

19.

Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, Dua A . An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs. 2006; 20(6):363-70. DOI: 10.2165/00063030-200620060-00007. View

20.

Goldman J, Le T, Skobe M, Swartz M . Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin. Circ Res. 2005; 96(11):1193-9. DOI: 10.1161/01.RES.0000168918.27576.78. View